Friday, December 28, 2018

PolarityTE Registers OsteoTE™ with U.S. Food and Drug Administration

SALT LAKE CITY, Dec. 28, 2018 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a commercial-stage biotechnology company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of...



from PR Newswire: https://prn.to/2RdVtgf

No comments:

Post a Comment